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ABSTRACT
A roundtable discussion held at the fourth International Symposium on the Environmental Dimension of Antibiotic
Resistance (EDAR4) considered key issues concerning the impact on the environment of antibiotic use in agriculture and
aquaculture, and emissions from antibiotic manufacturing. The critical control points for reducing emissions of antibiotics
from agriculture are antibiotic stewardship and the pre-treatment of manure and sludge to abate antibiotic-resistant
bacteria. Antibiotics are sometimes added to fish and shellfish production sites via the feed, representing a direct route of
contamination of the aquatic environment. Vaccination reduces the need for antibiotic use in high value (e.g. salmon)
production systems. Consumer and regulatory pressure will over time contribute to reducing the emission of very high
concentrations of antibiotics from manufacturing. Research priorities include the development of technologies, practices
and incentives that will allow effective reduction in antibiotic use, together with evidence-based standards for antibiotic
residues in effluents. All relevant stakeholders need to be aware of the threat of antimicrobial resistance and apply best
practice in agriculture, aquaculture and pharmaceutical manufacturing in order to mitigate antibiotic resistance
development. Research and policy development on antimicrobial resistance mitigation must be cognizant of the varied
challenges facing high and low income countries.
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The fourth International Symposium on the Environmental Di-
mension of Antibiotic Resistance (EDAR4) held at Michigan State
University in August 2017 followed the EDAR3 symposium held
in Germany in 2015 (Smalla et al. 2016). Key issues concerning
agriculture, aquaculture and antibiotic manufacturing were de-
liberated in a roundtable discussion. The authors of this paper
were the roundtable participants, but the approximately 100 in-
dividuals in attendance also contributed greatly to the delibera-
tions. Informed by this discussion, this paper is intended to pro-
vide a perspective on where we have been, and where we need
to go on these matters. These discussions were timely in light
of the recent (December 2017) draft resolution by the United Na-
tions Environment Assembly on Environment and Health that
clearly articulates the concern for the environmental dimension
of antimicrobial resistance (resolution UNEP/EA.3/L.8/REV.1;
https://papersmart.unon.org/resolution/index).
AGRICULTURE
The use of antibiotics in food-animal production selects for and
enriches antibiotic resistance (Hoelzer et al. 2017). In the past
several years we have obtained a clearer understanding of the
microbial composition of animal waste using molecular tools.
But, in general, we do not have a clear understanding of the re-
lationship between antibiotic use and the burden of enteric an-
timicrobial resistance inmanures. This is further complicated by
co-selection in which the development of resistance to in-feed
metals (Zn, Cu) may be accompanied by the development of re-
sistance to antibiotics. Inventories of antibiotic-resistance genes
from shotgun metagenomics do not provide a genetic context,
and therefore the potential for horizontal gene transfer, and do
not provide insights into functional expression. Two further con-
textual challenges involve i) coming to terms with the abun-
dance and diversity of ‘natural’ resistance in soil communities,
and ii) the development of realistic target ranges for reducing
resistance in agricultural environments impacted by antibiotic
residues of crop and animal origin.
Recent insights into particular agroecological niches are en-
abling scientists to better understand environmental factors af-
fecting horizontal gene transfer in agroecosystems. Of particu-
lar interest is the plant rhizosphere where nutrient resources
and active microbial groups are in close proximity to crops used
for livestock or human consumption (Kopmann et al. 2013). Tar-
geting management efforts to the particular niches where hor-
izontal gene transfer is most promiscuous and where there is
the potential for microbes to easily leap into the animal or hu-
man microbiome makes good sense compared with large-scale
potentially expensive whole-farm soil and manure treatment.
Numerous investigations (Jia et al. 2017; Tien et al. 2017; Yoon
et al. 2017) concerning the impact of manure treatment options
typically used on commercial farms indicate that these do not
always effectively reduce, and in some instances (e.g. anaero-
bic digestion) may increase, the abundance of some antibiotic-
resistance genes. Further research into effective and economi-
cally viable treatment of agricultural waste streams is required.
Over the past decades, initiatives to streamline antibiotic
use in animals have evolved in higher income countries. Swe-
den banned the use of antibiotic growth promoters as early
as 1986, a move that was followed gradually by the whole EU
implementing a total ban on antibiotic growth promoter use
by 2006. In North America the use of antibiotics for growth
promotion is being constrained. In some sectors (e.g. poultry)
producers are reducing antimicrobial use due to consumer de-
mand for antibiotic-free products. For more than 10 years now,
stakeholder platforms such as RUMA (UK) and EPRUMA (EU)
have been promoting responsible use of medicines, including
antibiotics in animals. These platforms have a broad member-
ship of farmers, veterinarians, pharmaceutical companies and
feed producer associations and also include regulators such as
the European Commission. Starting in 2007, the EU has built
antibiotic use surveillance capacity with its ESVAC programme
(http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulati
on/document listing/document listing 000302.jsp) while some
of its member states have had use monitoring in place since
the 1990s. Since 2009, there has been a clear decrease in
antibiotic use in animals in the EU, which is predicted to
steadily continue in the years ahead. In the USA, annual sales of
antibiotics are monitored and published by the Food and Drug
Administration, but a decrease in use has not been observed
thus far. Surveillance of antimicrobial use in animals, where
available, generally follows official antibiotic sales, not actual
use. It is therefore often not possible to know the antibiotic
consumption by individual commodity groups. Most countries
do not implement surveillance for antimicrobial resistance in
animal pathogens; where resistance surveillance is in place,
this mostly concerns commensal and zoonotic bacteria. How-
ever, diagnostic laboratories in, for example, Sweden, Germany
and France are required to publish information on antibiotic
resistance in animal pathogens, and it would greatly help global
data coordination if this practice were to be adopted by other
countries using a harmonised approach (Schrijver et al. 2018).
While there clearly is a serious situation with antimicrobial
resistance in human medicine, multidrug resistance in animal
pathogens is far less well documented.
In lower income countries, challenges are often greater. An-
tibiotic use in low income settings is very poorly regulated, and
there are few or no surveillance data. Consumer demand in
China and India for meat protein and the adoption of commer-
cial production practices in which antibiotics are widely em-
ployed have the potential to massively increase the global use
of antibiotics in agriculture (Van Boeckel et al. 2015).
For antibiotic use in animals to decline, innovations are
needed in technology and practice that keep farmers profitable
whilemaintaining animal welfare and ensuring food safety (Van
Boeckel et al. 2017). Vaccines, feed additives, improved biosecu-
rity and barn design appropriate for each commodity may each
have a role. Recent research in antimicrobial alternatives con-
tinues, but it must be paired with a thorough analysis of their
effects on antimicrobial resistance. Including copper or zinc in
livestock diets is often considered as an alternative to an an-
tibiotic. Soils in Denmark showed greater concentrations of cop-
per and zinc as antibiotic use was curtailed (Jensen, Larsen and
Bak 2016), and both elements can enrich tetracycline resistance
in soil (Song et al. 2017). As changes in food-animal production
practices are implemented, potential changes in the broader
agroecosystems need to be assessed. Unfortunately, to date no
effective alternative to antibiotics for the treatment of diseased
animals has been discovered. Since it is unlikely that any new
antibiotics will be introduced for veterinary use in the future, it
is essential for animal health and livestock production to main-
tain the efficacy of existing veterinary antibiotics through stew-
ardship, and further research is needed into efficient and viable
techniques to limit the potential spread of resistant bacteria and
genes.
On the other hand, farmers and veterinarians in low income
countries that face food insecurity often experience difficulties
in accessing effective antibiotics to treat their livestock. The sup-
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compromised by counterfeiting. The latter constitutes a high
risk for selection and dissemination of resistant bacteria, while
compromising the health of the animals, and hence increases
food insecurity. Recycling wastewater for crop irrigation is com-
monly practiced in low income countries, and is becoming in-
creasingly so in arid regions of middle and high income coun-
tries. The risks of soil, water and crop contamination, and
how these vary with production practice, remain to be ade-
quately characterised (Christou et al. 2017). Wastewater reuse
and fertilization with sewage sludge have the potential to en-
train antibiotic-resistant bacteria selected for in humans into
agroecosystems (Lau et al. 2017), underscoring the complexity
of the issue.
AQUACULTURE
The significance of aquaculture as a source of fish and shell-
fish has increased tremendously in the past 50 years (Watts
et al. 2017). Approximately 90% of global aquaculture production
is now undertaken in Norway, Chile, Egypt, and several Asian
countries with China accounting for two-thirds of global pro-
duction (FAO 2015; Liu et al. 2017). The steep increase in produc-
tion has happened in the same period of time when antibiotic
consumption has multiplied, but there is no clear relationship
between those events. The term aquaculture refers to very dif-
ferent activities ranging from extensive aquaculture where the
predators and competitive species are removed, to the most in-
tensive aquaculture where all food needs are supplied. More-
over, the term covers everything from farming salmon offshore
in cold Atlantic waters to tropical integrated aquaculture where
livestock manure and excess animal feed are the nutrients for
aquaculture ponds. Moreover, the economic conditions in the
countries with substantial aquaculture vary from extremely
wealthy to very poor. There is therefore tremendous diversity in
antibiotic use in aquaculture with, for example, 13 different an-
tibiotics authorised for use in aquaculture in China, compared
with only five in the UK (Liu et al. 2017). Antibiotic residues can
be detected in aquaculture products, and among these oxytetra-
cycline and its epimers were the ones most commonly detected
in a recent American study investigating aquaculture-derived
products imported from a variety of countries (Done and Halden
2015). However, by analysing the data available from different
aquaculture settings, some conclusions can be drawn regarding
best aquaculture practice with respect to managing antibiotic
resistance.
Antibiotic use in aquaculture in Europe, Northern America
and Japan is strictly controlled and limited to therapeutic ap-
plications, with only a limited number of approved antibiotics.
A prime example of the effect of rigorous control on antibiotic
use is the Norwegian experience, where antibiotic use was re-
duced by 99% between 1987 and 2013, despite a more than
20-fold increase in production over this time (Norwegian Min-
istry of Health and Care Services 2015). The main factors be-
hind that development were implementation of strict hygienic
requirements and use of vaccines, which were at least partly
the result of active scientific research in the field. Vaccina-
tion is an economically viable practice with high value species
such as salmon, which, however, represent only a small fraction
of global aquaculture production. In contrast, over 90% of the
world aquaculture production is carried out in low- or middle-
income countries where the regulation, practices and resources
are much more limited (Watts et al. 2017). Even with the same
fish species the use of antibiotics in aquaculture can vary enor-
mously. For example, the production of 1 tonne of salmon in
Norway requires 0.0008 kg of antibiotics whereas 1.4 kg of antibi-
otics are used per tonne of salmon produced in Chile (Cabello et
al. 2013). The reasons behind this vast difference are not entirely
clear but in the Chilean context include lack of vaccination, high
animal density and sub-optimal farming practices. The latter in-
clude underdeveloped hygiene and use of feeds with unknown
components that may contain unknown antibiotics at unknown
dosage. Likewise, aquaculture systems that integrate the wastes
from livestock production are efficient with respect to nutrient
cycling, but have additional potential problems with antibiotic
resistance (Cabello et al. 2016).
Aquaculture products are an important source of export in-
come for many low- and middle-income countries. Products
destined for export are strictlymonitored for antibiotic residues,
and concentrations within the product must fall below interna-
tionally accepted minimum residue limits. In contrast products
containing an antibiotic above the minimum residue limit can
be consumed domestically. The application of antibiotics to the
aquatic environment may select for antibiotic-resistance genes
not only in fish pathogens, but also in environmental bacteria
(Muziasari et al. 2016). Some antibiotic-resistance genes confer-
ring resistance to certain antibiotics such as quinolones, tetra-
cyclines and β-lactams can be found in fish pathogens, human
pathogens and aquatic bacteria, which are suspected of being
the original hosts for these genes (Cabello et al. 2013). Rico et al.
(2018) assessed the risks for development of resistance for 12
antibiotics in an intensive aquaculture production scenario us-
ing a probabilistic approach. Risks were high for all antibiotics in
pond sediment and high for the majority of antibiotics in pond
water. Risks were low in the effluent mixing area for most an-
tibiotics, with the exception of rifampicin and levofloxacin. Fish
farms using tetracyclines have been found to increase the di-
versity of tetracycline antibiotic-resistance genes in river water,
while no significant differences in the abundance of antibiotic-
resistant bacteria and antibiotic-resistance genes were seen be-
tween upstream, post-treatment or downstream water samples
(Harnisz, Korzeniewska and Golaś 2015). These studies suggest
that the effective means of treating effluent from fish ponds is a
matter for further research.
The practical reality is that fish or other aquaculture species
in ponds or sea cages attract pathogens that require either pre-
vention or treatment, and very few alternatives to antibiotics
are currently available (Defoirdt, Sorgeloos and Bossier 2011).
Because of the ever increasing importance of aquaculture for
the global food supply, research into vaccines has stepped up
in the past decades and this is encouraging. Fish DNA vaccines
are very effective as demonstrated by the Norwegian experi-
ence. But they are difficult and expensive to deploy. Currently
every fish must be injected so the skill level for management is
very high. Further research into more practical means of vac-
cine administration is warranted to increase overall vaccine use
in aquaculture as a valuable alternative to prevention of disease
by antibiotics.
MANUFACTURING
The highest concentrations of antibiotics and the highest abun-
dances of antibiotic-resistance genes detected in the environ-
ment are found in environments polluted by direct discharges
from the manufacturing of antibiotics (Larsson 2014; Pal et al.
2016). Major discharges, in the mg/L range, clearly selective for
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regions (Larsson 2014; Bielen et al. 2017). Accordingly, there is
a growing consensus from major pharmaceutical companies,
academia and other actors that managing and reducing such
discharges is important and urgent. Compared with agricul-
tural and human sources, industrial point sources for antibiotics
and antibiotic-resistant bacteria are considerably fewer, making
themamore graspable target, both economically and practically.
Still, there are major knowledge gaps in how widespread infe-
rior pollution control is, but perhapsmost importantly, there are
knowledge gaps with regards to how improvements are best in-
centivised and implemented.
Regulatory requirements for manufacturing sites and emis-
sion control worldwide vary from being non-existent to the
application of high standards. Where they exist, environmen-
tal permits are provided and controlled by individual countries
or states, again with vast differences in requirements and en-
forcement. The production and supply chain for antibiotics of-
ten involves several steps and actors in different parts of the
world, providing challenges for the end producer, and to an even
larger extent the consumer, to gain insight into and influence
over the degree of environmental pollution control in the early,
most critical steps of production of active ingredient and for-
mulated product. Antibiotic discharges are rarely regulated di-
rectly, although discharge limits have recently been proposed
(Bengtsson-Palme and Larsson 2016). India is the first country
to explicitly have declared an intent to regulate antibiotic emis-
sions nationally (Government of India 2017). Increased trans-
parency has been stressed as a critical measure (Larsson and
Fick 2009) to create pressure on manufacturers, a measure that,
at least for the EU market, would be helped by making parts of
the existing registration dossiers public. The strong price pres-
sure on the generics market, together with substitution systems
for generic exchange in human medicine, has not favoured in-
vestments in pollution control and has played a role in the re-
location of production facilities to countries with lower produc-
tion costs and also less strict environmental regulation. One pos-
sible way to incentivise ‘green’ investments would be to value
documented pollution control, in addition to low price, when
exchangeable products eligible for tax subsidy are identified
(Bengtsson-Palme, Gunnarsson and Larsson 2018). Other means
involve the inclusion of pollution control in procurement pro-
cesses, and in public ranking/benchmarking schemes for drug
companies (Access to Medicines Foundation 2017; Bengtsson-
Palme, Gunnarsson and Larsson 2018).
Initiatives from industry are also critical. In 2006, the Phar-
maceutical Supply Chain Initiative (PSCI; https://pscinitiative
.org/home) was formed, with the broader aim of establishing
and promoting responsible practices to continuously improve
social, health, safety and environmentally sustainable outcomes
for pharmaceutical and healthcare supply chains. Currently, 26
companies have joined the PSCI; themembership shares knowl-
edge and expertise and this includes supplier and auditor con-
ferences and training. Such alliances of companies are much
more successful in driving change compared with individual
companies alone. This initiative is fully operational and has a
growing membership.
Thirteen leading pharmaceutical companies have recently
signed up to the Industry Roadmap for Progress on Combating
Antimicrobial Resistance (IFPMA, 2016). The roadmap includes
key measures on reviewing manufacturing and supply chains,
a common framework for managing antibiotic discharge, in-
creased transparency, and the establishment of appropriate tar-
gets for discharge concentrations andmethods to achieve these.
An apparent challenge is how to reach companies that are not
involved in these initiatives. Industries producingmainly for na-
tionalmarkets, particularly in low andmiddle income countries,
may be considerably more difficult to incentivise from abroad,
and would be more dependent on national regulations and
enforcement.
GENERAL CONCLUSIONS
Education on best practices of all parties involved in the distribu-
tion and use of antibiotics in terrestrial or aquatic food produc-
tion systems is key to implementing antibiotic stewardship. Dig-
ital communication tools (e.g. mobile phones) could have an im-
portant role in providing stakeholders (e.g. veterinarians, farm-
ers) with useful information and guidance and this needs to
be developed. Consumer demand is having variable impact on
the global demand for antibiotics. On the one hand the demand
for antibiotic-free meats is increasing in high income countries.
In some instances (e.g. Sweden) hospital organizations are in-
creasingly including environmental contamination control dur-
ing manufacturing in their procurement of antibiotics. On the
other hand, rising income in lower income countries is increas-
ing themarket for animal proteins, driving the increasing imple-
mentation of production practices that rely heavily on antibiotic
use. It is very important to note that good animal production
practice varies tremendously across different commodities, dif-
ferent levels of economic development and different climates.
No one set of policies or practices or any one technology will
have a substantial impact on reducing antimicrobial use in ev-
ery region or on every farm or aquaculture facility. Thus it is im-
portant to engage policy-makers, researchers and food-animal
producers in every region to grapple with this global problem.
China unveiled an antimicrobial resistance action plan in 2016,
and India intends to drastically curtail antibiotic emissions from
the manufacturing sector by 2020. These are very positive de-
velopments. Finally, science-based standards for acceptable an-
tibiotic concentrations (and antibiotic-resistance genes) in ter-
restrial and aquatic food-animal production environments and
manufacturing effluents are required to inform policy and stan-
dards. This is clearly an important research priority.
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